Nazione: Irlanda
Lingua: inglese
Fonte: HPRA (Health Products Regulatory Authority)
Fexofenadine hydrochloride
Opella Healthcare France SAS T/A Sanofi
R06AX; R06AX26
Fexofenadine hydrochloride
120 milligram(s)
Film-coated tablet
Other antihistamines for systemic use; fexofenadine
Not marketed
2013-03-01
PACKAGE LEAFLET: INFORMATION FOR THE USER TELFAST ALLERGY 120 MG FILM COATED TABLETS Fexofenadine hydrochloride READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. Always take this medicine exactly as described in this leaflet or as your doctor or pharmacist has told you. - Keep this leaflet. You may need to read it again. - Ask your pharmacist if you need more information or advice. - If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. - You must talk to a doctor if you do not feel better or if you feel worse. WHAT IS IN THIS LEAFLET: 1. What Telfast Allergy is and what it is used for 2. What you need to know before you take Telfast Allergy 3. How to take Telfast Allergy 4. Possible side effects 5. How to store Telfast Allergy 6. Contents of the pack and other information 1. WHAT TELFAST ALLERGY IS AND WHAT IT IS USED FOR Telfast Allergy 120 mg film-coated-tablets (called Telfast Allergy throughout this leaflet) contains fexofenadine hydrochloride, which is a non-drowsy antihistamine. Telfast Allergy is used in adults and adolescents of 12 years and older to relieve the symptoms that occur with allergic rhinitis (for example hay fever), such as sneezing, itchy, runny or blocked nose and itchy, red and watery eyes. 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE TELFAST ALLERGY DO NOT TAKE Telfast Allergy if you are allergic to fexofenadine or any of the other ingredients of this medicine (listed in section 6). WARNINGS AND PRECAUTIONS Talk to your doctor or pharmacist before taking Telfast Allergy if: you have problems with your liver or kidneys you have or ever had heart disease, since this kind of medicine may lead to a fast or irregular heart beat you are elderly. If any of these apply to you, or if you are not sure, tell your doctor before taking Telfast Allergy. OTHER MEDICINES AND TELFAST ALLERGY Tell your doctor or pharmacist if you Leggi il documento completo
Health Products Regulatory Authority 26 March 2024 CRN00DWTL Page 1 of 6 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Telfast Allergy 120 mg film-coated tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains 120 mg of fexofenadine hydrochloride, which is equivalent to 112 mg of fexofenadine. For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Film-coated tablet Peach, modified capsule-shaped, film-coated tablet debossed with ‘012’ on one side and a scripted ‘e’ on the other side. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Telfast Allergy 120 mg is indicated in adults and children 12 years and older for the relief of symptoms associated with allergic rhinitis. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology _Adults _ The recommended dose of fexofenadine hydrochloride for adults is 120 mg once daily taken before a meal. Fexofenadine is a pharmacologically active metabolite of terfenadine. _PAEDIATRIC POPULATION_ Children aged 12 years and over The recommended dose of fexofenadine hydrochloride for children aged 12 years and over is 120 mg once daily taken before a meal. Children under 12 years of age The efficacy and safety of fexofenadine hydrochloride 120mg has not been studied in children under 12. In children from 6 to 11 years of age: fexofenadine hydrochloride 30 mg tablet is the appropriate formulation for administration and dosing in this population. _SPECIAL POPULATIONS_ Studies in special risk groups (older people, renally or hepatically impaired patients) indicate that it is not necessary to adjust the dose of fexofenadine hydrochloride in these patients 4.3 CONTRAINDICATIONS Hypersensitivity to the active substance or to any of the excipients listed in section 6.1. Health Products Regulatory Authority 26 March 2024 CRN00DWTL Page 2 of 6 4.4 SPECIAL WARNINGS AND PRECAUTIONS FOR USE There is limited data in the elderly and renally or hepatically impaired patients. Fexofenadine hydrochloride should be administered with ca Leggi il documento completo